Latest News

• Alert FDA OKs Elacestrant for ESR1+ Advanced, Metastatic Breast Cancer The phase 3 data showed a 2-month progression-free survival benefit with elacestrant versus fulvestrant or an aromatase inhibitor.
  Medscape Medical News, January 27, 2023
• Alert FDA Approves Pirtobrutinib for R/R Mantle Cell Lymphoma This drug is the first BTK inhibitor approved to treat mantle cell lymphoma in this setting. Approval was based on overall response rates and duration of response in the phase 1/2 BRUIN trial.
  Medscape Medical News, January 27, 2023
• Even One Head Injury Boosts All-Cause Mortality Risk Sustaining even a single head injury is linked to a significantly increased risk for all-cause mortality, new research shows.
  Medscape Medical News, January 27, 2023
• CV Deaths Jumped in 2020, Reflecting Pandemic Toll The American Heart Association 2020 Statistical Update offers lessons for addressing structural issues that drive health disparities.
  Medscape Medical News, January 27, 2023
• New Imaging Score May Predict Chemo Benefit in Early OPSCC If validated, this scoring system could help identify patients with oropharyngeal squamous cell carcinoma who can skip chemo. The study was published as a preprint and has not yet been peer reviewed.
  First Look, January 27, 2023
• Long COVID Affecting More Than 33% of College Students, Faculty The median age of participants was 23 years. The study is unique for evaluating mostly healthy, young adults and for its rare look at long COVID in a university community.
  WebMD Health News, January 27, 2023
• FDA to Ease Blood Donation Restrictions for Gay, Bisexual Men The proposed guidance would evaluate all potential donors on the basis of their individual risks of HIV infection.
  Medscape Medical News, January 27, 2023
• 'Kafkaesque Nightmare': Judge Wants Researcher Reinstated Judge Block emphasized that one of the world's leading molecular biologists disagreed with the investigation committee's conclusion that Dr Blain committed research misconduct.
  Retraction Watch, January 27, 2023
• Proof Lacking for Dual-Targeted Therapy Benefit in IBD Questions remain unanswered about the effectiveness of combination biologic treatment for inflammatory bowel disease.
  MDedge News, January 27, 2023
• How Should PRAME Be Used to Evaluate Melanocytic Lesions? One potential pitfall with the test is that sun-damaged melanocytes may express PRAME, according to Cora Humberson, MD.
  MDedge News, January 27, 2023
• Female Doctors Have Higher Infertility Rates: What Can Be Done? Data show female physicians have higher risks for infertility and pregnancy loss than the general public. What can be done in a rigorous medical culture that challenges the term 'family friendly?'
  Medscape Medical News, January 27, 2023
• Pediatricians, Specialists Largely Agree on ASD Diagnoses General pediatricians and a multidisciplinary team of specialists agreed most of the time on which children should be diagnosed with autism spectrum disorder.
  MDedge News, January 27, 2023
• Food Additives May Exacerbate IBD Emulsifiers and thickeners added to food in processing may contribute to inflammation and changes in gut microbiota.
  MDedge News, January 27, 2023
• Novavax Needs 6 Months to Produce Annual COVID Shots That Match New Variants Novavax said on Thursday it would require 6 months to produce a COVID-19 vaccine designed to match whichever coronavirus variants are circulating for an annual immunization program each fall season in the US.
  Reuters Health Information, January 27, 2023
• Which Populations Should Be Screened for Cervical Cancer? Lesbians, many transgender men, and women who are not sexually active are at risk for cervical cancer and are recommended to undergo screening.
  Medscape Medical News, January 27, 2023
• Disparities in Breast Cancer Deaths, MRI Screening Persist Even after ACA expansion, the use of advanced breast MRI still lags in Black women, who are disproportionately affected by more aggressive breast cancers.
  Medscape Medical News, January 27, 2023
• California Law Aiming to Curb COVID Misinformation Blocked by Judge A US judge has blocked a California law that sought to penalize doctors who spread 'misinformation or disinformation' about COVID-19 while he considers a pair lawsuits challenging it on free speech grounds.
  Reuters Health Information, January 26, 2023
• Staffing Woes Set to Weigh on Hospital Operator's Profits Hospital operators in the U.S. are likely to see a dip in fourth-quarter profits as an ongoing staffing crunch limits their ability to take advantage of an early onset of the flu season and boost admissions.
  Reuters Health Information, January 26, 2023
• Income Could Plunge for Out-of-Network Doctors It has become increasingly difficult for doctors to boost their earnings by dropping insurance contracts.
  Medscape Medical News, January 27, 2023
• Biosimilar Equal to Natalizumab for Relapsing-Remitting MS A novel biosimilar matches natalizumab in terms of efficacy, safety, and immunogenicity in patients with relapsing remitting multiple sclerosis, results from a new phase 3 trial show.
  Medscape Medical News, January 27, 2023